Want to join the conversation?
$OXM expects 3Q to be the smallest sales and earnings quarter of fiscal year reflecting normal seasonality of Tommy Bahama and Lilly Pulitzer businesses. $OXM expects net sales of $220-230MM compared to net sales of $198.6MM in 3Q15. For 3Q16, $OXM sees loss per share of $0.02-0.12 and adjusted results between loss of $0.05 and EPS of $0.05.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.